What does C‑ANCA (cytoplasmic anti‑neutrophil cytoplasmic antibody) mean?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 31, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

C-ANCA Meaning

C-ANCA (cytoplasmic anti-neutrophil cytoplasmic antibody) refers to a specific staining pattern seen on immunofluorescence testing where autoantibodies produce diffuse, fine granular cytoplasmic fluorescence in neutrophils, most commonly targeting the enzyme proteinase 3 (PR3), and is strongly associated with granulomatosis with polyangiitis (GPA). 1, 2

What C-ANCA Represents

C-ANCA is one of three immunofluorescence patterns used to detect anti-neutrophil cytoplasmic antibodies:

  • Cytoplasmic pattern (c-ANCA): Diffuse fine granular cytoplasmic fluorescence
  • Perinuclear pattern (p-ANCA): Perinuclear fluorescence
  • Atypical pattern (a-ANCA): Unusual nuclear or cytoplasmic patterns 3, 4

The "C" specifically denotes the cytoplasmic distribution of antibody staining when ethanol-fixed neutrophils are examined under immunofluorescence microscopy.

Target Antigen and Disease Association

C-ANCA typically targets proteinase 3 (PR3), an enzyme found in neutrophil primary granules. 1, 2 This PR3-ANCA combination is the serological hallmark of:

  • Granulomatosis with polyangiitis (GPA) - the primary association 1
  • Some cases of microscopic polyangiitis (MPA) 3
  • Rarely in other forms of vasculitis

About 90% of patients with active generalized GPA test positive for ANCA, with c-ANCA/PR3-ANCA being the predominant pattern. 2 GPA characteristically presents with necrotizing granulomatous inflammation affecting the upper/lower respiratory tract and kidneys, manifesting as destructive sinonasal lesions, pulmonary nodules, and pauci-immune glomerulonephritis. 1

Clinical Significance

The presence of c-ANCA/PR3-ANCA in the appropriate clinical context is sufficiently specific that immunosuppressive therapy should not be delayed while awaiting kidney biopsy confirmation, especially in rapidly deteriorating patients. 2 This reflects the high specificity (98.4% for c-ANCA by immunofluorescence) and the serious morbidity/mortality risk of untreated vasculitis. 5

Important Caveats:

  • A negative ANCA test does not exclude vasculitis - approximately 10% of AAV patients are persistently ANCA-negative 2
  • Antigen specificity (PR3 vs MPO) correlates more closely with disease phenotype and prognosis than the immunofluorescence pattern alone 6
  • Modern testing guidelines recommend screening with antigen-specific immunoassays (PR3-ANCA, MPO-ANCA) rather than relying solely on immunofluorescence patterns, as this improves diagnostic sensitivity without sacrificing specificity 2, 5

The c-ANCA pattern, when confirmed as PR3-specific, carries significant diagnostic weight for GPA and should prompt urgent evaluation for systemic vasculitis affecting kidneys, lungs, and upper airways.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.